Market revenue in 2021 | USD 15.2 million |
Market revenue in 2030 | USD 26.4 million |
Growth rate | 6.3% (CAGR from 2021 to 2030) |
Largest segment | Biomarker assay development & validation |
Fastest growing segment | Flow cytometry |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biomarker Assay Development & Validation, Flow cytometry, Others( Biomarker immunoassays, Biomarker Assessment) |
Key market players worldwide | Eurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Labcorp Drug Development, Thermo Fisher Scientific Inc, Icon PLC, IQVIA Holdings Inc, Syneos Health, Intertek Group PLC, BioAgilytix Labs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker testing services market will help companies and investors design strategic landscapes.
Biomarker assay development & validation was the largest segment with a revenue share of 59.87% in 2024. Horizon Databook has segmented the Middle East & Africa biomarker testing services market based on biomarker assay development & validation, flow cytometry, others( biomarker immunoassays, biomarker assessment) covering the revenue growth of each sub-segment from 2018 to 2030.
The biomarker testing services market in the MEA region will likely grow steadily in the coming years. Increasing privatization is the major factor contributing to the growth of the market. Moreover, increasing investment initiatives by the government to improve the region's healthcare system is also one factor driving the market growth.
However, the country's underdeveloped health infrastructure may hamper market growth in the forecasted period. For instance, the WHO International Clinical Trials Registry Platform (ICTRP) reports 861 clinical trials registered in Africa in 2022.
Moreover, less competition between pharmaceutical companies in underdeveloped countries of the region is encouraging various pharmaceutical startups in the region and thereby results in regional market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa biomarker testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa biomarker testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account